| 1 |
35391718 | Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. | 2022 |
1 |
| 2 |
34023505 | A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer. | 2021 Oct 6 |
2 |
| 3 |
34916377 | CXCR4 and RIF1 overexpression induces resistance of epithelial ovarian cancer to cisplatin-based chemotherapy. | 2021 Oct-Dec |
3 |
| 4 |
32390763 | TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. | 2020 |
3 |
| 5 |
30554431 | CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma. | 2019 Feb |
4 |
| 6 |
29436676 | Vandetanib inhibits cisplatin‑resistant neuroblastoma tumor growth and invasion. | 2018 Apr |
2 |
| 7 |
27922681 | CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. | 2017 Feb |
6 |
| 8 |
28196146 | Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer. | 2017 |
1 |
| 9 |
28446538 | Chitosan nanoparticle-delivered siRNA reduces CXCR4 expression and sensitizes breast cancer cells to cisplatin. | 2017 Jun 30 |
1 |
| 10 |
28498420 | CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo. | 2017 Jun |
1 |
| 11 |
28721072 | CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells. | 2017 |
1 |
| 12 |
26819076 | Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells. | 2016 Mar |
1 |
| 13 |
29797935 | [Investigation of CXCR4 mediated chemoresistance in nasopharyngeal carcinoma cell line CNE2]. | 2016 Jun 5 |
8 |
| 14 |
25544759 | Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin. | 2015 Jan 20 |
6 |
| 15 |
26020117 | Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. | 2015 May 28 |
1 |
| 16 |
26020124 | Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer. | 2015 Jul |
1 |
| 17 |
26141860 | Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis. | 2015 Sep 1 |
2 |
| 18 |
24209634 | Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer. | 2014 Jan |
5 |
| 19 |
24408020 | Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells. | 2014 May |
7 |
| 20 |
19671192 | Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells. | 2009 Aug 12 |
1 |
| 21 |
16331601 | Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. | 2006 May 1 |
2 |